Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Drug Pricing Hearing Takes A Partisan Turn As Gilead’s O’Day Holds His Own
May 17 2019
•
By
Cathy Kelly
Gilead CEO was on the hot seat at 16 May hearing.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access